Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (1.792)

21

Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients : experience from the initial use of lopinavir-ritonavir

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Gonzalez-García, R. | Roma, J. | Rodríguez-García, M. | +17

22

Beneficial effects of Naringin against lopinavir/ ritonavir-induced hyperlipidemia and reproductive toxicity in male albino rats

enthalten in: European review for medical and pharmacological sciences | 2023

von Krishnaraju, V. | Alghazwani, Y. | Durgaramani, S. | +9

23

Brief Report : Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Jacobs, T. | Mumbiro, V. | Chitsamatanga, M. | +48

24

Mechanistic in vitro studies indicate that the clinical drug-drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal BCRP and hepatic OATP1B1 with minimal contribution from OATP1B3, NTCP and OAT3

enthalten in: Pharmacology research & perspectives | 2023

von Elsby, R. | Coghlan, H. | Edgerton, J. | +3

25

Implications of the Digestion of Milk-Based Formulations for the Solubilization of Lopinavir/Ritonavir in a Combination Therapy

enthalten in: Molecular pharmaceutics | 2023

von Salim, M. | Ramirez, G. | Clulow, A. | +2

26

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial

enthalten in: Influenza and other respiratory viruses | 2023

von Alotaibi, F. | Alharbi, N. | Rosen, L. | +25

27

Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Mohsenian Naghani, S. | Jansen, M. | Jaspers, T. | +2

28

Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Skalafouris, C. | Samer, C. | Stirnemann, J. | +6

29

The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modeling

enthalten in: Drug metabolism and personalized therapy | 2023

von Alsmadi, M.

30

Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda

enthalten in: Clinical pharmacology and therapeutics | 2023

von Kay, K. | Goodwin, J. | Ehrlich, H. | +13